Axel Schonthal, Ph.D.

University of Southern California
email: schontha@usc.edu

Grants

Intranasal drug delivery for brain metastatic breast cancer 2013 (Cycle 19)
IDEA (Innovative, Developmental, and Exploratory Awards) 19IB-0141 $242,382


Preclinical development and clinical use of perillyl alcohol for chemoprevention and cancer therapy
  Periodical: American Journal of Cancer Research
  Author(s): Thomas C Chen, Clovis O Da Fonseca, Axel Schonthal
  Yr: 2015 Vol: 5 Nbr: 5 Pgs: 1580-1593
  Associated Grant: Intranasal drug delivery for brain metastatic breast cancer
 
A novel temozolomide-perillyl alcohol conjugate exhibits superior activity against breast cancer cells in vitro and intracranial triple-negative tumor growth in vivo.
  Periodical: Molecular Cancer Therapeutics
  Author(s): T.C. Chen, H.-Y. Cho, W. Wang, M. Barath, N. Sharma, F.M. Hofman, A.H. Schonthal
  Yr: 2014 Vol: 13 Nbr: 5 Pgs: 1181-93
  Associated Grant: Intranasal drug delivery for brain metastatic breast cancer